R01 CA100882/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2007	2
2008	6
2009	2
2010	6
2011	7
2012	6
2013	6
2014	2
2015	5
2016	1
2017	1
2024	0

1

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.

Andersen JB, Spee B, Blechacz BR, Avital I, Komuta M, Barbour A, Conner EA, Gillen MC, Roskams T, Roberts LR, Factor VM, Thorgeirsson SS. Andersen JB, et al. Gastroenterology. 2012 Apr;142(4):1021-1031.e15. doi: 10.1053/j.gastro.2011.12.005. Epub 2011 Dec 13. Gastroenterology. 2012. PMID: 22178589 Free PMC article.

2

Chemopreventive strategies in hepatocellular carcinoma.

Singh S, Singh PP, Roberts LR, Sanchez W. Singh S, et al. Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):45-54. doi: 10.1038/nrgastro.2013.143. Epub 2013 Aug 13. Nat Rev Gastroenterol Hepatol. 2014. PMID: 23938452 Free PMC article. Review.

3

Epidemiology and management of hepatocellular carcinoma.

Yang JD, Roberts LR. Yang JD, et al. Infect Dis Clin North Am. 2010 Dec;24(4):899-919, viii. doi: 10.1016/j.idc.2010.07.004. Infect Dis Clin North Am. 2010. PMID: 20937457 Free PMC article. Review.

4

Hepatocellular carcinoma: A global view.

Yang JD, Roberts LR. Yang JD, et al. Nat Rev Gastroenterol Hepatol. 2010 Aug;7(8):448-58. doi: 10.1038/nrgastro.2010.100. Epub 2010 Jul 13. Nat Rev Gastroenterol Hepatol. 2010. PMID: 20628345 Free PMC article. Review.

5

The tumor suppressor function of human sulfatase 1 (SULF1) in carcinogenesis.

Lai JP, Sandhu DS, Shire AM, Roberts LR. Lai JP, et al. J Gastrointest Cancer. 2008;39(1-4):149-58. doi: 10.1007/s12029-009-9058-y. Epub 2009 Apr 17. J Gastrointest Cancer. 2008. PMID: 19373441 Free PMC article. Review.

6

Myc, Max, and Mnt: molecular mechanisms of enhancement of cholangiocarcinogenesis by cholestasis.

Nakamura I, Roberts LR. Nakamura I, et al. Gastroenterology. 2011 Jul;141(1):32-4. doi: 10.1053/j.gastro.2011.05.022. Epub 2011 May 26. Gastroenterology. 2011. PMID: 21620848 Free PMC article. No abstract available.

7

The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.

Yang JD, Nakamura I, Roberts LR. Yang JD, et al. Semin Cancer Biol. 2011 Feb;21(1):35-43. doi: 10.1016/j.semcancer.2010.10.007. Epub 2010 Oct 12. Semin Cancer Biol. 2011. PMID: 20946957 Free PMC article. Review.

8

Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.

Lai JP, Thompson JR, Sandhu DS, Roberts LR. Lai JP, et al. Future Oncol. 2008 Dec;4(6):803-14. doi: 10.2217/14796694.4.6.803. Future Oncol. 2008. PMID: 19086847 Free PMC article. Review.

9

Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets.

Sandhu DS, Shire AM, Roberts LR. Sandhu DS, et al. Liver Int. 2008 Jan;28(1):12-27. doi: 10.1111/j.1478-3231.2007.01624.x. Epub 2007 Nov 21. Liver Int. 2008. PMID: 18031477 Free PMC article. Review.

10

Liver transplantation after radioembolization in a patient with unresectable HCC.

Luna LE, Kwo PY, Roberts LR, Mettler TA, Gansen DN, Andrews JC, Wiseman GA, Misra VL. Luna LE, et al. Nat Rev Gastroenterol Hepatol. 2009 Nov;6(11):679-83. doi: 10.1038/nrgastro.2009.165. Nat Rev Gastroenterol Hepatol. 2009. PMID: 19881519 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year